No abstract available
Publication types
-
Clinical Trial, Phase III
MeSH terms
-
Aged
-
Alzheimer Disease / drug therapy*
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Drug Approval*
-
Humans
-
Treatment Failure
Substances
-
Antibodies, Monoclonal, Humanized
-
solanezumab